Thanks, Doug, and hello to everyone on today's call. Our Q3 performance comes in the face of continued challenges across our end markets. The risks we anticipated last quarter played out as expected throughout this quarter. Our Q3 revenue of $51 million declined 1% versus last year, and our reported net income and adjusted EBITDA were both a loss of $10 million. Our adjusted EBITDA was heavily impacted by reserves we took against our most aged client balances. We saw 25% plus growth in paying clients during the third quarter, though this growth was fully offset by a decline in our revenue per paying client. We expected these pressures given the continued liquidity challenges that our clients are facing. Moving down the P&L. Our Q3 gross margin rate of 92% is consistent with the prior quarter. Our reported operating expenses after cost of revenues and before D&A expense came in at $63 million for the quarter, and includes $2 million in stock-based compensation along with $6 million in other non-recurring charges, which include severance payments associated with the headcount reduction we executed in August. More information on these charges is available in our earnings release and earnings slide deck and will be in our Form 10-Q. Excluding these items our non-GAAP adjusted OpEx for the quarter came in at $56 million, or a 46% increase versus last year resulting in our adjusted EBITDA loss. The largest driver of adjusted OpEx growth came from the bad debt expense we incurred, which I'll touch on now. Excluding bad debt from both this quarter and the prior year period, our adjusted OpEx grew by 27% year-over-year and adjusted EBITDA was $1 million. Over the past year, we selectively worked with certain clients who are facing difficulties to help them navigate through the challenging environment. We've talked previously about how we believe that supporting our clients during trying times like these will pay dividends when conditions improve. This quarter what became clear to us however is the prolonged time required for a return to growth across cannabis end markets. For example, the California market which contributed 53% of our total Q3 revenue saw year-over-year declines in statewide sales of minus 10% based on third-party data during the quarter. Given these dynamics, we made the decision to accelerate the reserves we're taking against a handful of clients some of whom remain on the platform at significantly downgraded levels of spend, others of whom have been unpublished as a result of their liquidity challenges. Our bad debt expense was a significant drag on our Q3 adjusted EBITDA, which was positive before this charge. Our bad debt is also limited to a handful of accounts that saw challenges earlier this year versus a wider spread issue. Approximately 90% of the bad debt we incurred in Q3 relates to 15 clients where we are now fully reserved against the majority of these accounts. What's encouraging is the decline we saw this quarter in our gross receivables balances. The third quarter is the first, since end market challenges began where the change in our receivables was a source of cash. We are very focused on where we're investing and firmly believe that we can find further opportunities to rationalize our spend, as we get back on the path towards cash flow generation. As Doug stated, we know we must do better in this environment on controlling our spend, and we'll continue to take action on productivity opportunities. Our reported net income loss of $10 million, includes $7 million gain in the fair value of our warrant liability. Our fully diluted share count across our Class A and B share classes was 146 million at the end of the quarter. A reconciliation of adjusted EBITDA to net income as well as the details of our share classes and share count calculation are provided in our earnings release posted to our Investor Relations site. We ended the quarter with $34 million in cash and no long-term debt. We continue to be comfortable with our liquidity position given the productivity initiatives that we've already taken and are continuing to take action against. Before I speak to our outlook for the fourth quarter, I also wanted to address our thinking on additional metrics for disclosure. I mentioned in our August earnings call that we've been evaluating additional metrics for investors to gauge the health of our business and progress in executing against our platform strategy. We've decided to sunset our prior MAU metric as, it's a very broad top of funnel metric that has become more correlated to our marketing investments and less correlated to our revenue growth. We expect to provide our additional metrics disclosure on our Q4 call in concert with our 2023 plan and guidance. More details on these changes can be found in our Form 10-Q filing. Now, I'll turn to our financial outlook for the fourth quarter and provide some commentary on how we're planning for fiscal year 2023. I noted on our August earnings call that, we were baking in risks in our scenario planning for the second half, including continued end market declines in Q3, bottoming out in Q4 along with continued liquidity challenges for our clients. Based on where we are today, we lack clear signs that end market challenges and client liquidity concerns have fully bottomed out. As such, we expect our second half revenue will decline closer to the wide end of our guidance range for the second half, or down in the mid-single-digit percentage area. We're continuing to execute against productivity actions, as I noted, but expect Q4 adjusted EBITDA will be further impacted by bad debt expense, which will remain elevated in Q4 though significantly lower than Q3. As Doug stated, we're currently working through our annual operating plans for next year and we'll provide more detailed guidance for 2023 at a later stage. With that said, I'd like to share some initial thoughts on where we're focusing our plans. As a backdrop to our planning, we expect visibility on a return to growth across licensed cannabis end markets will remain low. Against this backdrop, we're working towards creating more focus across our teams, more streamlined operations, and clear line of sight to positive cash flow. While the environment may remain uncertain our objective is to achieve profitability and positive cash flow in 2023. Our strategy remains unchanged. What has changed though is the focus we have on executing operationally, rightsizing our investments with rigorous prioritization, and delivering against our margin and cash flow potential regardless of the macro environment. In closing, Juan, myself and our entire leadership team are looking forward to partnering more closely with Doug and bringing WM Tech to its next phase of growth. His intimate knowledge of our company and end markets will serve us well as we get after the opportunities this year and complete our planning for 2023. With that, let's open up the call for questions.